Bexsero vaccine shortage in Australia

GSK's relatively new vaccine for meningococcal B is in low supply across the country due to its unexpected popularity worldwideBexsero is the only vaccine for meningococcal B currently registered for use in Australia and is relatively new, but overseas governments are cottoning on to the product, says GSK."Demand is increasing very rapidly, so we’re seeing

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous World news wrapup: 18 August 2016
Next Weekly Dose: teriparatide, the osteoporisis drug that forms new bone